v3.26.1
Stock Compensation Plans
 9 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Stock Compensation Plans STOCK COMPENSATION PLANS
The Company maintains one active stock compensation plan, the 2019 Equity Incentive Plan (the "2019 Plan"). Under the 2019 Plan, the Company may grant options and awards of restricted stock (with or without performance measures) for up to 350,000 shares of common stock, of which 300,000 shares are reserved for issuance to employees and officers, and 50,000 shares are reserved for issuance to directors and directors emeriti. Shares issued under the 2019 Plan may be purchased in the open market or issued from the Company's authorized and unissued shares.  The exercise price of each stock option equals the fair market value of the Company’s common stock on the date of grant. Stock options generally vest in equal annual installments over five years beginning on the first anniversary of the grant date and have a maximum contractual term of ten years. Restricted stock awards typically vest in equal annual installments over a three- or five-year period beginning on the first anniversary of the grant date. At June 30, 2026, 133,135 shares of common stock remained available for further issuance under the 2019 Plan, either as stock options or restricted stock awards.

The Company's 2014 Equity Incentive Plan (the "2014 Plan") expired on January 27, 2025; therefore, no further awards may be granted under the plan. As of June 30, 2026, there were 85,750 options outstanding to purchase shares of common stock that had been previously granted under the 2014 Plan, of which 74,150 were vested and 11,600 were unvested.

Stock option activity for the nine months ended June 30, 2026 and 2025, is summarized as follows:
Nine Months Ended June 30, 2026Nine Months Ended June 30, 2025
 Number of SharesWeighted
Average
Exercise
Price		 Number of SharesWeighted
Average
Exercise
Price
Options outstanding, beginning of period215,530 $26.22 306,240 $25.21 
Exercised(61,680)25.84 (41,960)19.47 
Forfeited(1,800)27.68 (11,300)28.41 
Options outstanding, end of period152,050 $26.35 252,980 $26.02 

The fair value of stock options is determined using the Black-Scholes valuation model.

There were no stock options granted during the nine months ended June 30, 2026 and 2025.
The aggregate intrinsic value of options exercised during the nine months ended June 30, 2026 and 2025 was $747,000 and $487,000, respectively.
At June 30, 2026, there were 33,200 unvested options with an aggregate grant date fair value of $221,000, all of which the Company assumes will vest. The aggregate intrinsic value of unvested options at June 30, 2026 was $567,000.  There were 300 options that vested during the nine months ended June 30, 2026 with a total fair value of $2,056.

At June 30, 2025, there were 69,430 unvested options with an aggregate grant date fair value of $421,000. There were 2,500 options that vested during the nine months ended June 30, 2025 with a total fair value of $16,000.
Additional information regarding options outstanding at June 30, 2026, is as follows:

Options OutstandingOptions Exercisable
Range of
Exercise
Prices ($)		NumberWeighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life (Years)		NumberWeighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life (Years)
15.67-19.1327,150 $16.60 3.327,150 $16.60 3.3
26.50-27.4057,525 27.34 5.635,325 27.30 5.1
28.23-29.6950,850 28.64 4.140,250 28.75 3.8
31.80-33.4016,525 31.90 2.516,125 31.86 2.4
152,050 $26.35 4.4118,850 $25.96 3.9

The aggregate intrinsic value of options outstanding at June 30, 2026 and 2025, was $2.81 million and $1.33 million, respectively.

As of June 30, 2026, unrecognized compensation cost related to unvested stock options was $127,000, which is expected to be recognized over a weighted average period of 0.92 years.

There were no restricted stock awards granted during the nine months ended June 30, 2026 and 2025.

The following table presents the activity related to restricted stock for the nine months ended June 30, 2026 and 2025:

Nine Months Ended June 30, 2026 Nine Months Ended June 30, 2025
Number of Unvested SharesWeighted Average Grant Date Fair ValueNumber of Unvested SharesWeighted Average Grant Date Fair Value
Restricted stock outstanding beginning of period70,450 $31.94 49,015 $29.28 
     Forfeited(2,280)29.93 (1,830)28.70 
     Vested— — (200)27.37 
Restricted stock outstanding end of period68,170 $32.00 46,985 $29.31 
The fair value of restricted stock awards is equal to the fair value of the Company's stock on the date of the grant. The related stock-based compensation expense is recorded over the requisite service period. At June 30, 2026, unrecognized compensation cost related to unvested restricted stock awards was $1.71 million, which is expected to be recognized over a weighted average period of 2.25 years.